<DOC>
	<DOC>NCT02069743</DOC>
	<brief_summary>The investigators have developed a mobile application (for use on smart phones) to help cancer patients better manage cancer pain. This study is a randomized controlled trial to evaluate the effect of this mobile-based intervention. The investigators' hypothesis is that subjects randomized to the intervention group will achieve greater reductions in cancer-related pain and improved quality of life.</brief_summary>
	<brief_title>Pain Management in Cancer Patients Using a Mobile Application</brief_title>
	<detailed_description />
	<criteria>All adult patients, 18 years and above suffering from solidorgan cancer. Diagnosed with moderate or severe cancer pain (i.e. pain intensity score of at least 4/10 on numeric rating scale (NRS)) at the Massachusetts General Hospital (MGH) Palliative Care Center, as determined by the patient's care provider at the MGH Palliative Care Center. Subjects do not need to experience a specific nature of pain for eligibility. Patients must be ambulatory and not currently admitted to the hospital at time of enrollment. Must have a smart phone and be willing to download the study application (Phase II only) Must be able to read and speak English. Life expectancy less than 2months as determined by the palliative care provider Significant medical or psychiatric comorbidities (other than depression or anxiety) or cognitive impediments that would prevent participant from being able to utilize the program Known history of substance abuse Patients currently on investigational therapies or other study protocols that may have an impact on pain intensity or quality of life which are main outcomes of this intervention.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>cancer pain</keyword>
</DOC>